Antimicrobial peptides: primeval molecules or future drugs?
- PMID: 21060861
- PMCID: PMC2965748
- DOI: 10.1371/journal.ppat.1001067
Antimicrobial peptides: primeval molecules or future drugs?
Conflict of interest statement
The authors have declared that no competing interests exist.
Figures
References
-
- Giuliani A, Pirri G, Nicoletto S. Antimicrobial peptides: an overview of a promising class of therapeutics. Cent Eur J Biol. 2007;2:1–33.
-
- Zasloff M. Antimicrobial peptides of multicellular organisms. Nature. 2002;415:389–395. - PubMed
-
- Shai Y. From innate immunity to de-novo designed antimicrobial peptides. Curr Pharm Des. 2002;8:715–725. - PubMed
-
- Kavanagh K, Dowd S. Histatins: antimicrobial peptides with therapeutic potential. J Pharm Pharmacol. 2004;56:285–289. - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
